Alan Davis is an Assistant Professor of Social Work at Ohio State University and Adjunct Assistant Professor in the Center for Psychedelic and Consciousness Research at Johns Hopkins University. Victor was also listed on the Students for Sensible Drug Policy’s list of ’40 Under 40 Outstanding BIPOC Leaders in Drug Policy in the United States’ for his work in psychedelic policy.ĭr. He is a research-based systems thinker with expertise in policy development, advocacy, consulting, racial and communal trauma, and is a practicing psychotherapist with training in Internal Family Systems, Psychedelic-Assisted Psychotherapy (MDMA and Ketamine), and other modalities.
![fluence photox fluence photox](https://cdn2.riastatic.com/photosnew/auto/photo/renault_fluence__462401737f.jpg)
Fluence photox free#
Before joining Fluence, Victor served as Deputy Director for the Pennsylvania Governor’s Office of Advocacy and Reform where he helped lead the implementation of the Trauma-Informed PA Plan, establish the first Racial Day of Healing in Pennsylvania history, and developed free trauma trainings for Pennsylvanians in collaboration with internationally recognized experts. Victor Cabral, MSW, LSW, CCTP-I (He/Him/His) is a collaborative and strategic leader who has made an impact on human rights and historical inequalities throughout his career. Having completed an NIH postdoctoral fellowship at NYU, she has published and presented on topics of psychedelic therapist training, therapists’ personal experience with psychedelics, and including psychedelic integration in group and individual psychotherapy.ĭirector of Policy and Regulatory Affairs
Fluence photox trial#
Her research includes qualitative and mixed-methods projects designed to further understand the phenomenology and mechanisms of change in psychedelic-assisted therapy, including the experiences of trial participants and of the therapists themselves.
![fluence photox fluence photox](https://qmotor.com/File/Images/carsphotos/143779/o_a3848156c4bdfc9c8fc98a0b3d00a6dba6e05386_17015105-c5dee1fb4a.png)
![fluence photox fluence photox](https://s1.cdn.autoevolution.com/images/gallery/RENAULT-Fluence-4166_55.jpg)
Through Fluence, she provides continuing education and training programs for therapists who wish to engage in integration of psychedelic experiences in clinical settings. Nielson is a Site Co-Principal Investigator and therapist for an FDA approved Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder, and has served as a therapist on FDA approved clinical trials of psilocybin-assisted treatment of alcohol use disorder, psilocybin-assisted treatment of treatment resistant depression, and earlier phase 2 and 3 trials of MDMA-assisted psychotherapy. Elizabeth Nielson is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders.